NIH and partners to launch HIV vaccine efficacy trial in
https://www.nih.gov/news-events/news-releases/nih-partners-launch-hiv-vaccine-efficacy-trial-americas-europe
Jul 15, 2019 . Mosaico will be the third HIV vaccine efficacy trial in progress worldwide. Imbokodo completed enrollment in May 2019 of 2,600 sexually active women aged between 18 and 35 years across Malawi, Mozambique, South Africa, Zambia and Zimbabwe. Initial results from this Phase 2b trial are anticipated in 2021. login
login
DA: 43 PA: 67 MOZ Rank: 92